{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T23:06:53Z","timestamp":1773011213103,"version":"3.50.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T00:00:00Z","timestamp":1576108800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T00:00:00Z","timestamp":1576108800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Microbiol"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s00203-019-01789-8","type":"journal-article","created":{"date-parts":[[2020,4,19]],"date-time":"2020-04-19T22:02:36Z","timestamp":1587333756000},"page":"773-784","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Efficacy of voriconazole in vitro and in invertebrate model of cryptococcosis"],"prefix":"10.1007","volume":"202","author":[{"given":"Cristina","family":"de Castro Spadari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda Walt Mendes","family":"da Silva de Bastiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro Bruno Bautista","family":"Pisani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Analy Salles","family":"de Azevedo Melo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4602-0926","authenticated-orcid":false,"given":"Kelly","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,12]]},"reference":[{"key":"1789_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/aac.00321-17","volume":"61","author":"IA Alves","year":"2017","unstructured":"Alves IA, Staudt KJ, Silva CdeM, Lock GdeA, Dalla Costa T, de Araujo BV (2017) Influence of experimental cryptococcal meningitis in Wistar rats on voriconazole brain penetration assessed by microdialysis. Antimicrob Agents Chemother 61:1\u20138. https:\/\/doi.org\/10.1128\/aac.00321-17","journal-title":"Antimicrob Agents Chemother"},{"key":"1789_CR2","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3389\/fmicb.2015.00367","volume":"6","author":"S Amorim-Vaz","year":"2015","unstructured":"Amorim-Vaz S, Delarze E, Ischer F, Sanglard D, Coste AT (2015) Examining the virulence of Candida albicans transcription factor mutants using Galleria mellonella and mouse infection models. Front Microbiol 6:367. https:\/\/doi.org\/10.3389\/fmicb.2015.00367","journal-title":"Front Microbiol"},{"key":"1789_CR3","doi-asserted-by":"publisher","first-page":"e01179-17","DOI":"10.1128\/aac.01179-17","volume":"62","author":"RW Bastos","year":"2018","unstructured":"Bastos RW, Carneiro HCS, Oliveira LVN, Rocha KM, Freitas GJC, Costa MC, Magalh\u00e3es TFF, Carvalho VSD, Rocha CE, Ferreira GF, Paix\u00e3o TA, Moyrand F, Janbon G, Santos DA (2018) Environmental triazole induces cross-resistance to clinical drugs and affects morphophysiology and virulence of Cryptococcus gattii and C. neoformans. Antimicrob Agents Chemother 62:e01179-17. https:\/\/doi.org\/10.1128\/aac.01179-17","journal-title":"Antimicrob Agents Chemother"},{"key":"1789_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2016.00290","volume":"7","author":"T Benaducci","year":"2016","unstructured":"Benaducci T, Sardi JdeCO, Lourencetti NMS, Scorzoni L, Gullo FP, Rossi SA, Derissi JB, de AzevedoPrata MC, Fusco-Almeida AM, Mendes-Giannini MJS (2016) Virulence of Cryptococcus sp. biofilms in vitro and in vivo using Galleria mellonella as an alternative model. Front Microbiol 7:1\u201310. https:\/\/doi.org\/10.3389\/fmicb.2016.00290","journal-title":"Front Microbiol"},{"key":"1789_CR5","doi-asserted-by":"publisher","first-page":"4074","DOI":"10.1128\/AAC.00172-10","volume":"54","author":"E Calvo","year":"2010","unstructured":"Calvo E, Pastor FJ, Rodriguez MM, Pujol I, Guarro J (2010) Antifungal therapy in a murine model of disseminated infection by Cryptococcus gattii. Antimicrob Agents Chemother 54:4074\u20134077. https:\/\/doi.org\/10.1128\/AAC.00172-10","journal-title":"Antimicrob Agents Chemother"},{"key":"1789_CR6","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/S1369-5274(00)00103-X","volume":"3","author":"A Casadevall","year":"2000","unstructured":"Casadevall A, Rosas AL, Nosanchuk JD (2000) Melanin and virulence in Cryptococcus neoformans. Curr Opin Microbiol 3:354\u2013358. https:\/\/doi.org\/10.1016\/S1369-5274(00)00103-X","journal-title":"Curr Opin Microbiol"},{"key":"1789_CR7","unstructured":"CLSI (2008) Reference method for broth dilution antifungal susceptibility testing of yeasts: approved standard, 3rd edn. CLSI document M27-A3, Clinical & Laboratory Standards Institute, pp 1\u201325"},{"key":"1789_CR8","doi-asserted-by":"publisher","first-page":"3107","DOI":"10.1128\/AAC.48.8.3107-3111.2004","volume":"48","author":"M Cuenca-Estrella","year":"2004","unstructured":"Cuenca-Estrella M, Gomez-Lopez A, Mellado E, Garcia-Effron G, Rodriguez-Tudela JL (2004) In vitro activities of ravuconazole and four other antifungal agents against fluconazole-resistant or -susceptible clinical yeast isolates. Antimicrob Agents Chemother 48:3107\u20133111. https:\/\/doi.org\/10.1128\/AAC.48.8.3107-3111.2004","journal-title":"Antimicrob Agents Chemother"},{"key":"1789_CR9","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1128\/EC.3.5.1067-1075.2004","volume":"3","author":"M Del Poeta","year":"2004","unstructured":"Del Poeta M (2004) Role of phagocytosis in the virulence of Cryptococcus neoformans. Eukaryot Cell 3:1067\u20131075. https:\/\/doi.org\/10.1128\/EC.3.5.1067-1075.2004","journal-title":"Eukaryot Cell"},{"key":"1789_CR10","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1093\/infdis\/jiu441","volume":"211","author":"A Desalermos","year":"2015","unstructured":"Desalermos A, Tan X, Rajamuthiah R, Arvanitis M, Wang Y, Li D, Kourkoumpetis TK, Fuchs BB, Mylonakis E (2015) A multi-host approach for the systematic analysis of virulence factors in Cryptococcus neoformans. J Infect Dis 211:298\u2013305. https:\/\/doi.org\/10.1093\/infdis\/jiu441","journal-title":"J Infect Dis"},{"key":"1789_CR11","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/myc.12112","volume":"57","author":"F Fern\u00e1ndez-Silva","year":"2014","unstructured":"Fern\u00e1ndez-Silva F, Capilla J, Mayayo E, Guarro J (2014) Modest efficacy of voriconazole against murine infections by Sporothrix schenckii and lack of efficacy against Sporothrix brasiliensis. Mycoses 57:121\u2013124. https:\/\/doi.org\/10.1111\/myc.12112","journal-title":"Mycoses"},{"key":"1789_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mycmed.2015.12.006","volume":"26","author":"M Frenkel","year":"2016","unstructured":"Frenkel M, Mandelblat M, Alastruey-Izquierdo A, Mendlovic S, Semis R, Segal E (2016) Pathogenicity of Candida albicans isolates from bloodstream and mucosal candidiasis assessed in mice and Galleria mellonella. J Mycol Med 26:1\u20138. https:\/\/doi.org\/10.1016\/j.mycmed.2015.12.006","journal-title":"J Mycol Med"},{"key":"1789_CR13","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.celrep.2015.01.009","volume":"10","author":"JA Hill","year":"2015","unstructured":"Hill JA, O\u2019Meara TR, Cowen LE (2015) Fitness trade-offs associated with the evolution of resistance to antifungal drug combinations. Cell Rep 10:809\u2013819. https:\/\/doi.org\/10.1016\/j.celrep.2015.01.009","journal-title":"Cell Rep"},{"key":"1789_CR14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1476-0711-8-29","volume":"8","author":"K Ishida","year":"2009","unstructured":"Ishida K, Rozental S, de Mello JCP, Nakamura CV (2009) Activity of tannins from Stryphnodendron adstringens on Cryptococcus neoformans: effects on growth, capsule size and pigmentation. Ann Clin Microbiol Antimicrob 8:29. https:\/\/doi.org\/10.1186\/1476-0711-8-29","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"1789_CR15","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.fbr.2010.04.001","volume":"24","author":"K Kavanagh","year":"2010","unstructured":"Kavanagh K, Fallon JP (2010) Galleria mellonella larvae as models for studying fungal virulence. Fungal Biol Rev 24:79\u201383. https:\/\/doi.org\/10.1016\/j.fbr.2010.04.001","journal-title":"Fungal Biol Rev"},{"key":"1789_CR16","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/ncn3.116","volume":"2","author":"Y Koike","year":"2014","unstructured":"Koike Y, Ishihara T, Ozawa T, Mezaki N, Moro H, Shimohata T, Nishizawa M (2014) Cryptococcal meningitis successfully treated with voriconazole and low-dose amphotericin B. Neurol Clin Neurosci 2:166\u2013168. https:\/\/doi.org\/10.1111\/ncn3.116","journal-title":"Neurol Clin Neurosci"},{"key":"1789_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1473-3099(17)30303-1","volume":"3099","author":"AH Limper","year":"2017","unstructured":"Limper AH, Adenis A, Le T, Harrison TS (2017) Fungal infections in HIV\/AIDS. Lancet Infect Dis 3099:1\u201310. https:\/\/doi.org\/10.1016\/S1473-3099(17)30303-1","journal-title":"Lancet Infect Dis"},{"key":"1789_CR18","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1146\/annurev.micro.60.080805.142102","volume":"60","author":"X Lin","year":"2006","unstructured":"Lin X, Heitman J (2006) The biology of the Cryptococcus neoformans species complex. Annu Rev Microbiol 60:69\u2013105. https:\/\/doi.org\/10.1146\/annurev.micro.60.080805.142102","journal-title":"Annu Rev Microbiol"},{"key":"1789_CR19","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.cell.2008.07.046","volume":"135","author":"OW Liu","year":"2008","unstructured":"Liu OW, Chun CD, Chow ED, Chen C, Madhani HD, Noble SM (2008) Systematic genetic analysis of virulence in the human fungal pathogen Cryptococcus neoformans. Cell 135:174\u2013188. https:\/\/doi.org\/10.1016\/j.cell.2008.07.046","journal-title":"Cell"},{"key":"1789_CR20","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.simyco.2015.12.001","volume":"81","author":"XZ Liu","year":"2015","unstructured":"Liu XZ, Wang QM, G\u00f6ker M, Groenewald M, Kachalkin AV, Lumbsch HT, Millanes AM, Wedin M, Yurkov AM, Boekhout T, Bai FY (2015) Towards an integrated phylogenetic classification of the Tremellomycetes. Stud Mycol 81:85\u2013147. https:\/\/doi.org\/10.1016\/j.simyco.2015.12.001","journal-title":"Stud Mycol"},{"key":"1789_CR21","doi-asserted-by":"publisher","first-page":"419","DOI":"10.4161\/viru.24930","volume":"4","author":"JMS Loh","year":"2013","unstructured":"Loh JMS, Adenwalla N, Wiles S, Proft T (2013) Galleria mellonella larvae as an infection model for group A streptococcus. Virulence 4:419\u2013428. https:\/\/doi.org\/10.4161\/viru.24930","journal-title":"Virulence"},{"key":"1789_CR22","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12906-015-0597-4","volume":"15","author":"RLF Luiz","year":"2015","unstructured":"Luiz RLF, Vila TVM, de Mello JCP, Nakamura CV, Rozental S, Ishida K (2015) Proanthocyanidins polymeric tannin from Stryphnodendron adstringens are active against Candida albicans biofilms. BMC Complement Altern Med 15:68. https:\/\/doi.org\/10.1186\/s12906-015-0597-4","journal-title":"BMC Complement Altern Med"},{"key":"1789_CR23","doi-asserted-by":"publisher","first-page":"6350","DOI":"10.1128\/IAI.73.10.6350","volume":"73","author":"LR Martinez","year":"2005","unstructured":"Martinez LR, Casadevall A (2005) Specific antibody can prevent fungal biofilm formation and this effect correlates with protective efficacy. Infect Immun 73:6350\u20136362. https:\/\/doi.org\/10.1128\/IAI.73.10.6350","journal-title":"Infect Immun"},{"key":"1789_CR24","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1128\/AAC.50.3.1021-1033.2006","volume":"50","author":"LR Martinez","year":"2006","unstructured":"Martinez LR, Casadevall A (2006a) Susceptibility of Cryptococcus neoformans biofilms to antifungal agents in vitro. Antimicrob Agents Chemother 50:1021\u20131033. https:\/\/doi.org\/10.1128\/AAC.50.3.1021-1033.2006","journal-title":"Antimicrob Agents Chemother"},{"key":"1789_CR25","doi-asserted-by":"publisher","first-page":"6118","DOI":"10.1128\/IAI.00995-06","volume":"74","author":"LR Martinez","year":"2006","unstructured":"Martinez LR, Casadevall A (2006b) Cryptococcus neoformans cells in biofilms are less susceptible than planktonic cells to antimicrobial molecules produced by the innate immune system. Infect Immun 74:6118\u20136123. https:\/\/doi.org\/10.1128\/IAI.00995-06","journal-title":"Infect Immun"},{"key":"1789_CR26","doi-asserted-by":"publisher","first-page":"4592","DOI":"10.1128\/AEM.02506-06","volume":"73","author":"LR Martinez","year":"2007","unstructured":"Martinez LR, Casadevall A (2007) Cryptococcus neoformans biofilm formation depends on surface support and carbon source and reduces fungal cell susceptibility to heat, cold, and UV light. Appl Environ Microbiol 73:4592\u20134601. https:\/\/doi.org\/10.1128\/AEM.02506-06","journal-title":"Appl Environ Microbiol"},{"key":"1789_CR27","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s11046-006-0039-4","volume":"162","author":"N Mavrogiorgos","year":"2006","unstructured":"Mavrogiorgos N, Zaragoza O, Casadevall A, Nosanchuk JD (2006) Efficacy of voriconazole in experimental Cryptococcus neoformans infection. Mycopathologia 162:111\u2013114. https:\/\/doi.org\/10.1007\/s11046-006-0039-4","journal-title":"Mycopathologia"},{"key":"1789_CR28","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.idc.2015.10.006","volume":"30","author":"EK Maziarz","year":"2016","unstructured":"Maziarz EK, Perfect JR (2016) Cryptococcosis. Infect Dis Clin North Am 30:179\u2013206. https:\/\/doi.org\/10.1016\/j.idc.2015.10.006","journal-title":"Infect Dis Clin North Am"},{"key":"1789_CR29","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1128\/AAC.46.2.556-557.2002","volume":"46","author":"J Mosquera","year":"2002","unstructured":"Mosquera J, Denning DW (2002) Azole cross-resistance in Aspergillus fumigatus. Antimicrob Agents Chemother 46:556\u2013557. https:\/\/doi.org\/10.1128\/AAC.46.2.556-557.2002","journal-title":"Antimicrob Agents Chemother"},{"key":"1789_CR30","doi-asserted-by":"publisher","first-page":"3842","DOI":"10.1128\/IAI.73.7.3842-3850.2005","volume":"73","author":"E Mylonakis","year":"2005","unstructured":"Mylonakis E, Moreno R, El Khoury JB, Idnurm A, Heitman J, Calderwood SB, Ausubel FM, Diener A (2005) Galleria mellonella as a model system to study Cryptococcus neoformans pathogenesis. Infect Immun 73:3842\u20133850. https:\/\/doi.org\/10.1128\/IAI.73.7.3842-3850.2005","journal-title":"Infect Immun"},{"key":"1789_CR31","doi-asserted-by":"publisher","DOI":"10.1590\/s1678-9946201759049","author":"E Nascimento","year":"2017","unstructured":"Nascimento E, Vitali LH, Kress MRVZ, Martinez R (2017) Cryptococcus neoformans and C gattii isolates from both HIV-infected and uninfected patients: antifungal susceptibility and outcome of cryptococcal disease. Rev Inst Med Trop Sao Paulo. https:\/\/doi.org\/10.1590\/s1678-9946201759049","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"1789_CR32","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.2217\/fmb-2017-0062","volume":"12","author":"AC Palanco","year":"2017","unstructured":"Palanco AC, De Lacorte Singulani J, Costa-Orlandi CB, Gullo FP, Strohmayer Lourencetti NM, Gomes PC, Ayusso GM, Dutra LA, Da Silva Bolzani V, Regasini LO, Soares Mendes-Giannini MJ, Fusco-Almeida AM (2017) Activity of 3\u2032-hydroxychalcone against Cryptococcus gattii and toxicity, and efficacy in alternative animal models. Future Microbiol 12:1123\u20131134. https:\/\/doi.org\/10.2217\/fmb-2017-0062","journal-title":"Future Microbiol"},{"key":"1789_CR33","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/cid\/ciw444","volume":"63","author":"TF Patterson","year":"2016","unstructured":"Patterson TF, Thompson GR, Denning DW, Fishman JA, Hadley S, Herbrecht R, Kontoyiannis DP, Marr KA, Morrison VA, Nguyen MH, Segal BH, Steinbach WJ, Stevens DA, Walsh TJ, Wingard JR, Young J-AH, Bennett JE (2016) Bennett, Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis 63:433\u2013442. https:\/\/doi.org\/10.1093\/cid\/ciw444","journal-title":"Clin Infect Dis"},{"key":"1789_CR34","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2147\/tcrm.2006.2.2.129","volume":"2","author":"J Pem\u00e1n","year":"2006","unstructured":"Pem\u00e1n J, Salavert M, Cant\u00f3n E, Jarque I, Rom\u00e1 E, Zaragoza R, Viudes \u00c1, Gobernado M (2006) Voriconazole in the management of nosocomial invasive fungal infections. Ther Clin Risk Manag 2:129\u2013157. https:\/\/doi.org\/10.2147\/tcrm.2006.2.2.129","journal-title":"Ther Clin Risk Manag"},{"key":"1789_CR35","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1086\/374557","volume":"36","author":"JR Perfect","year":"2003","unstructured":"Perfect JR, Marr KA, Walsh TJ, Greenberg RN, DuPont B, de la Torre-Cisneros J, Just-Nubling G, Schlamm HT, Lutsar I, Espinel-Ingroff A, Johnson E (2003) Voriconazole treatment for less-common, emerging, or refractory fungal infections. Clin Infect Dis 36:1122\u20131131. https:\/\/doi.org\/10.1086\/374557","journal-title":"Clin Infect Dis"},{"key":"1789_CR36","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1086\/649858","volume":"50","author":"JR Perfect","year":"2010","unstructured":"Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, Hamill RJ, Harrison TS, Larsen RA, Lortholary O, Nguyen M-H, Pappas PG, Powderly WG, Singh N, Sobel JD, Sorrell TC (2010) Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of America. Clin Infect Dis 50:291\u2013322. https:\/\/doi.org\/10.1086\/649858","journal-title":"Clin Infect Dis"},{"key":"1789_CR37","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1128\/AAC.43.1.169","volume":"43","author":"MA Pfaller","year":"1999","unstructured":"Pfaller MA, Zhang J, Messer SA, Brandt ME, Hajjeh RA, Jessup CJ, Tumberland M, Mbidde EK, Ghannoum MA (1999) In vitro activities of voriconazole, fluconazole, and itraconazole against 566 clinical isolates of Cryptococcus neoformans from the United States and Africa. Antimicrob Agents Chemother 43:169\u2013171. https:\/\/doi.org\/10.1128\/AAC.43.1.169","journal-title":"Antimicrob Agents Chemother"},{"key":"1789_CR38","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.diagmicrobio.2003.09.008","volume":"48","author":"M Pfaller","year":"2004","unstructured":"Pfaller M, Messer S, Boyken L, Hollis R, Rice C, Tendolkar S, Diekema D (2004a) In vitro activities of voriconazole, posaconazole, and fluconazole against 4,169 clinical isolates of Candida spp. and Cryptococcus neoformans collected during 2001 and 2002 in the ARTEMIS global antifungal surveillance program. Diagn Microbiol Infect Dis 48:201\u2013205. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2003.09.008","journal-title":"Diagn Microbiol Infect Dis"},{"key":"1789_CR39","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1128\/CMR.17.2.268-280.2004","volume":"17","author":"MA Pfaller","year":"2004","unstructured":"Pfaller MA, Sheehan DJ, Rex JH (2004b) Determination of fungicidal activities against yeasts and molds: lessons learned from bactericidal testing and the need for standardization. Clin Microbiol Rev 17:268\u2013280. https:\/\/doi.org\/10.1128\/CMR.17.2.268-280.2004","journal-title":"Clin Microbiol Rev"},{"key":"1789_CR51","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1600-0560.2010.01626.x","volume":"38","author":"LP Quintella","year":"2011","unstructured":"Quintella LP, Lambert Passos SR, Francesconi Do Vale AC, Gutierrez Galhardo MC, De Lima Barros MB, Cuzzi T, Dos Santos Reis R, Figueiredo De Carvalho MHG, Zappa MB, De Oliveira Schubach A (2011) Histopathology of cutaneous sporotrichosis in Rio de Janeiro: a series of 119 consecutive cases. J Cutan Pathol 38:25\u201332. https:\/\/doi.org\/10.1111\/j.1600-0560.2010.01626.x","journal-title":"J Cutan Pathol"},{"key":"1789_CR40","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/S1473-3099(17)30243-8","volume":"17","author":"R Rajasingham","year":"2017","unstructured":"Rajasingham R, Smith RM, Park BJ, Jarvis JN, Govender NP, Chiller TM, Denning DW, Loyse A, Boulware DR (2017) Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis. Lancet Infect Dis 17:873\u2013881. https:\/\/doi.org\/10.1016\/S1473-3099(17)30243-8","journal-title":"Lancet Infect Dis"},{"key":"1789_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.00325","author":"SS Rathore","year":"2016","unstructured":"Rathore SS, Raman T, Ramakrishnan J (2016) Magnesium ion acts as a signal for capsule induction in Cryptococcus neoformans. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2016.00325","journal-title":"Front Microbiol"},{"key":"1789_CR42","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/myc.12510","volume":"59","author":"F Reichert-Lima","year":"2016","unstructured":"Reichert-Lima F, Busso-Lopes AF, Lyra L, Peron IH, Taguchi H, Mikami Y, Kamei K, Moretti ML, Schreiber AZ (2016) Evaluation of antifungal combination against Cryptococcus spp. Mycoses 59:585\u2013593. https:\/\/doi.org\/10.1111\/myc.12510","journal-title":"Mycoses"},{"key":"1789_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2016.00153","volume":"7","author":"SA Rossi","year":"2016","unstructured":"Rossi SA, Trevijano-Contador N, Scorzoni L, Mesa-Arango AC, de Oliveira HC, Werther K, de Freitas Raso T, Mendes-Giannini MJS, Zaragoza O, Fusco-Almeida AM (2016) Impact of resistance to fluconazole on virulence and morphological aspects of Cryptococcus neoformans and Cryptococcus gattii Isolates. Front Microbiol 7:1\u201314. https:\/\/doi.org\/10.3389\/fmicb.2016.00153","journal-title":"Front Microbiol"},{"key":"1789_CR44","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1128\/AAC.00163-06","volume":"50","author":"F Sabatelli","year":"2006","unstructured":"Sabatelli F, Patel R, Mann PA, Mendrick CA, Norris CC, Hare R, Loebenberg D, Black TA, McNicholas PM (2006) In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts. Antimicrob Agents Chemother 50:2009\u20132015. https:\/\/doi.org\/10.1128\/AAC.00163-06","journal-title":"Antimicrob Agents Chemother"},{"key":"1789_CR45","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1021\/pr401075f","volume":"13","author":"L Santi","year":"2014","unstructured":"Santi L, Beys-Da-Silva WO, Berger M, Calzolari D, Guimar\u00e3es JA, Moresco JJ, Yates JR (2014) Proteomic profile of Cryptococcus neoformans biofilm reveals changes in metabolic processes. J Proteome Res 13:1545\u20131559. https:\/\/doi.org\/10.1021\/pr401075f","journal-title":"J Proteome Res"},{"key":"1789_CR46","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1093\/jac\/dkm123","volume":"60","author":"C Serena","year":"2007","unstructured":"Serena C, Pastor FJ, Marin\u00e9 M, Rodr\u00edguez MM, Guarro J (2007) Efficacy of voriconazole in a murine model of cryptococcal central nervous system infection. J Antimicrob Chemother 60:162\u2013165. https:\/\/doi.org\/10.1093\/jac\/dkm123","journal-title":"J Antimicrob Chemother"},{"key":"1789_CR47","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.mib.2016.07.018","volume":"34","author":"LM Taylor-Smith","year":"2016","unstructured":"Taylor-Smith LM, May RC (2016) New weapons in the Cryptococcus infection toolkit. Curr Opin Microbiol 34:67\u201374. https:\/\/doi.org\/10.1016\/j.mib.2016.07.018","journal-title":"Curr Opin Microbiol"},{"key":"1789_CR48","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/jof5010003","volume":"5","author":"N Trevijano-Contador","year":"2018","unstructured":"Trevijano-Contador N, Zaragoza O (2018) Immune response of Galleria mellonella against human fungal pathogens. J Fungi 5:3. https:\/\/doi.org\/10.3390\/jof5010003","journal-title":"J Fungi"},{"key":"1789_CR49","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1128\/AAC.48.6.2014-2020.2004","volume":"48","author":"D van Duin","year":"2004","unstructured":"van Duin D, Cleare W, Zaragoza O, Casadevall A, Nosanchuk JD (2004) Effects of voriconazole on Cryptococcus neoformans. Antimicrob Agents Chemother 48:2014\u20132020. https:\/\/doi.org\/10.1128\/AAC.48.6.2014-2020.2004","journal-title":"Antimicrob Agents Chemother"},{"key":"1789_CR50","unstructured":"World Health Organization (2018) Guidelines for the diagnosis, prevention and management of cryptococcal disease in HIV-infected adults, adolescents and children: supplement to the 2016 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. WHO, p 23. http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/260399\/9789241550277-eng.pdf;jsessionid=04435249DFBDD7B62C8B6AEEE4928A4F?sequence=1. Accessed 3 Oct 2018"},{"key":"1789_CR52","doi-asserted-by":"publisher","first-page":"694","DOI":"10.3109\/23744235.2015.1044260","volume":"47","author":"Y Yao","year":"2015","unstructured":"Yao Y, Zhang J-T, Yan B, Gao T, Xing X-W, Tian C-L, Huang X-S, Yu S-Y (2015) Voriconazole: a novel treatment option for cryptococcal meningitis. Infect Dis (Auckl) 47:694\u2013700. https:\/\/doi.org\/10.3109\/23744235.2015.1044260","journal-title":"Infect Dis (Auckl)"},{"key":"1789_CR53","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3109\/13693786.2011.554893","volume":"49","author":"L Yong","year":"2011","unstructured":"Yong L (2011) Voriconazole: may be an option for treatment of cryptococcal meningitis. Med Mycol 49:335. https:\/\/doi.org\/10.3109\/13693786.2011.554893","journal-title":"Med Mycol"}],"container-title":["Archives of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-019-01789-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00203-019-01789-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-019-01789-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T00:20:33Z","timestamp":1607646033000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00203-019-01789-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,12]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["1789"],"URL":"https:\/\/doi.org\/10.1007\/s00203-019-01789-8","relation":{},"ISSN":["0302-8933","1432-072X"],"issn-type":[{"value":"0302-8933","type":"print"},{"value":"1432-072X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,12]]},"assertion":[{"value":"23 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}